Management of atopic dermatitis.
Rasmussen
J E
JE
Department of Dermatology, University of Michigan, Ann Arbor.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000150:complications / Q000209:etiology / Q000628:therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use; D004391:Dust / Q000009:adverse effects; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D005228:Fatty Acids, Essential / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000628:therapy; D008041:Linoleic Acids; D008925:Mites / Q000276:immunology; D031665:Oenothera biennis; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010938:Plant Oils; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D014466:Ultraviolet Rays; D017965:gamma-Linolenic Acid
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D004391:Dust; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D010726:Phosphodiesterase Inhibitors; D010938:Plant Oils; D013256:Steroids; C028498:evening primrose oil; D017965:gamma-Linolenic Acid; D015118:Eicosapentaenoic Acid